Morepen Labs Board Meeting on Aug 4 to Approve Q1 FY27 Results

Morepen Laboratories Ltd has announced a Board of Directors meeting scheduled for August 4, 2026. The primary agenda items include the consideration and approval of the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the board will fix the record date for determining eligibility for the final dividend for the financial year ended March 31, 2026. The trading window for designated persons and their immediate relatives will remain closed until 48 hours after the declaration of these financial results, extending to August 6, 2026.